. Consistent with its role as a negative feedback enzyme, expression of 24-OHase is sensitively induced by 1,25-(OH) 2 D itself through binding of liganded vitamin D receptor (VDR) and its heterodimeric partner , the retinoid X receptor (RXR) to vitamin D-responsive elements (VDRE) in the promoter region of CYP24 (6, 7) . Thus, the 24-OHase plays an important role in attenuating the potentially detrimental hypercalcemic side-effects of vitamin D by catalyzing the catabolism of active 1,25-(OH) 2 D to less-active downstream metabolites and by competing with 1α-OHase for their common substrate, 25-OHD (8, 9) .
Although proximal tubule epithelial cells are the major source of 1,25(OH) 2 D detectable in the circulation, it is now clear that 1α-OHase is expressed by many extra-renal tissues, including the skin, macrophages, placenta, colon, brain, prostate and endothelium (10) (11) (12) (13) (14) . At these sites 1α-OHase has been postulated to act in an autocrine or paracrine fashion by increasing local concentrations of 1,25-(OH) 2 D in a tissue-specific manner. Whereas, kidney-synthesized 1,25-(OH) 2 D functions to systemically regulate serum calcium and phosphorous levels for bone homeostasis (15) , extra-renal production of 1,25-(OH) 2 D appears to play an important role in cell differentiation, proliferation (16) and immune responsivity (17) .
Synthesis of 1,25-(OH) 2 D in peripheral tissues is catalyzed by the same 1α-OHase gene product that is present in the kidney (18, 19) , but the manner by which expression and activity of the enzyme are regulated is distinct. From an endocrine standpoint 1,25-(OH) 2 D tightly controls its own synthesis by: 1] inhibition of parathyroid hormone (PTH) gene expression; 2] induction of 24-OHase catabolic function (6) (7) (8) (9) ; 3] direct, negative regulation of CYP27B1 transcription (20) . By contrast, the abundant extra-renal production of 1,25-(OH) 2 D by cells such as activated macrophages is characterized by: 1] unresponsiveness to stimulation by PTH (21) ; 2] lack of feedback inhibition of 1α-OHase by 1,25-(OH) 2 D itself (22, 23) ; 3] relatively low levels of 1,25-(OH) 2 D-directed catabolic 24-hydroxylase activity (22, 24) . The latter mechanism appears to be particularly important in macrophages because CYP24 gene expression is readily stimulated by 1,25-(OH) 2 D in these cells without any apparent induction of catabolic 24-OHase enzyme activity (25) . To clarify this we have characterized a novel mechanism for the regulation of 1,25-(OH) 2 D production in macrophages which involves alternative splicing of the CYP24 gene and expression of a catalytically inactive, aminoterminally-truncated 24-OHase protein. As such, regulated expression of the CYP24 splice variant (CYP24-SV) can rheostatitically control the production of 1,25-(OH) 2 D in macrophages.
MATERIALS AND METHODS
Cell Culture HD-11 cells were generously provided by Dr. T. Graf (EMBO, Heidleberg, Germany) and grown in monolayers in Dulbecco's Modified Eagle's medium (DMEM, GibcoBRL, Gaithersburg, MD) supplemented with 15% fetal bovine serum (FBS, Omega, Tarzana, CA), 4mM L-glutamine, 100 u/ml penicillin and 100 µg/ml streptomycin (GibcoBRL) at 37° C in a humidified atmosphere of 5% CO 2 and 95% air. Human monocytic THP-1 cells (American Type Culture Collection, Manassas, VA; Cat. No. TIB-202) were grown in suspension in RPMI 1640 medium with 2 mM L-glutamine, 10 mM HEPES, 1 mM sodium pyruvate, 4.5 g/L glucose and 1.5 g/L bicarbonate, supplemented with 10% fetal bovine serum (v/v) and 0.05 mM 2-mercaptoethanol. Differentiated THP-1 cells (dTHP-1) with macrophage characteristics were produced by treating THP-1 cells with 160 nM tetradecanoylphorbol acetate (TPA, Sigma, St. Louis, MO) in regular culture medium for 24 hrs. After 24 hrs treatment, the cells were 80%-90% adherent, and the medium containing TPA was replaced with normal culture medium for cell maintenance until experimental reagents were added. In addition to the HD-11 and THP-1 cells, other human cells were used for RT-PCR analysis of CYP24 expression.
These included HKC-8 proximal tubules cells [26] and peripheral blood derived macrophages [27] and reverse primer 5'-CTCTGCTAAGCGACGGC CAATGC (1389-1367). PCR was carried out using the Advantage cDNA PCR Kit (Clontech) applying the following parameters: 94° C for 3 min followed by 30 cycles of denaturation at 94° C for 12 sec and annealing/extension at 68° C for 3 min with a final extension of 3 min at 68° C. The PCR products were separated by electrophoresis on a 1.2% agarose (GibcoBRL) gel with a 1 Kb Plus DNA Ladder (GibcoBRL) as a size marker and visualized by ethidium bromide staining. The predicted sizematched bands on the gel were purified by QIAquick Gel Extraction Kit (QIAGEN, Hilden, Germany) and cloned into the PCR4-TOPO plasmid vector and TOP10 competent E. coli cells using the TOPO TA Cloning Kit (Invitrogen, Carlsbad, CA). The selected, subcloned E. coli cells were cultured and subjected to the plasmid extraction by the PlasmidPURE DNA Mini-Prep Kit (SIGMA, St. Louis, MO). From purified plasmids the PCR products of interest were then sequenced by an automatic sequencing machine (ABI PRISM 377 DNA Sequencer, Applied Biosystems, Foster City, CA).
Isolation of full-length cDNAs for the CYP24 variants
To obtain a full-length cDNA for the CYP24 splice variants isolated from HD-11 cells, 5'-and 3'-RACE procedures were performed using the GeneRacer Kit (Invitrogen). PolyA RNA was extracted from cultured HD-11 cells pre-incubated with 200nM 1,25-(OH) 2 D for 24 hr using the Oligotex Direct mRNA Purification Kit (QIAGEN). Random and oligo dT (16) primers were used for reverse transcription to produce cDNA templates for 5'-and 3'-RACE respectively. Two pairs of the nested PCR primers were synthesized for 5'-and 3'-RACE separately, according to the cDNA sequences available from RT-PCR results above: reverse primer A 5'-CTCTGCTAAGCGACGGCCAATGC (CYP24 cDNA 1389-1367) and reverse primer B 5'-CCAGTTTCACCACCTCCTTGGGTTTCATCAG (508-478) for 5'-RACE; forward primer A 5' -GAGAAACTGCAACGCGCG TCACTCA (1611-1635) and forward primer B 5'-CCCCTGGTTGGAATTCCCTTAT TGG (1672-1696) for 3'-RACE. Because of the GC-rich region at the 5' end of the template, DMSO (5%, SIGMA) was added in the PCR cocktail for 5'-RACE reactions.
The RACE products were sequenced as described above.
PCR and GenomeWalker analysis of CYP24 genomic DNA sequences
To acquire further sequence information for the chick CYP24 gene, genomic DNA was extracted from cultured HD-11 cells by QIAmp Blood Kit (QIAGEN). PCR primers were derived from the cDNA sequences determined from RT-PCR and RACE results described above: forward primer 5'-AGATGCCTCCCTGCACGTGTCGTA (CYP24-SV cDNA 125-148) and reverse primer 5'-CCACAGGTGTCACCATCATCATTCC (CYP24-SV cDNA 516-492). PCR was carried out using the Advantage-GC Genomic PCR Kit (Clontech) with a 1 M GC-Melt concentration and the same cycle parameters described for the RT-PCR reactions. The 5' flanking genomic DNA sequence of chick CYP24 gene was obtained from HD-11 cell genomic DNA using the Universal GenomeWalker Kit (Clontech) and the Advantage-GC Genomic PCR Kit (Clontech) according to the manufacturer's protocols. The nested antisense primers arising from the 5' end of CYP24-SV cDNA were reverse primer 'A' 5'-CCAGTTTCACCACCTCCTTGGGT TTCATCAG (CYP24-SV cDNA 270-240) and reverse primer 'B' 5'-CTCTGCCAGT CCTTTCCTTCCCTAGGCGTAA (214-184). The products of PCR and GenomeWalker were cloned and sequenced as described above. 
Cloning and sequencing of a human form of CYP24-SV

Northern blot analysis
Total RNA was extracted from HD-11 cells using the same conditions and methods as described above in the "RT-PCR analysis of mRNA" section. Aliquots (50 µg) of total RNA were loaded in each lane and separated by electrophoresis using a 1% agarose (GibcoBRL)-2.2 M formaldehyde (J. T. Baker, Phillipsburg, NJ) gels containing ethidium bromide. The resolved RNA was transferred onto nylon membranes (Millipore Corp. Bedford, MA) in 10 X SSC buffer (0.3 M NaCl/0.03 M sodium citrate, pH 7) for 16 hr. The transferred filters were prehybridized with QuikHyb Hybridization Solution (Stratagene, Lo Jolla, CA) at 68° C for 1 hr, then hybridized in the same solution at 68° C for 12 hr to a random primed [ 32 P]-labeled 715 bp probe (wild type CYP24 cDNA 1104-1819) sharing the same cDNA sequences between the chick CYP24 and its splice variant. The filters were then washed in 0.1 X SSC/0.1% SDS at 55° C for 30 min and exposed to x-ray film at -70° C overnight.
Preparation of polyclonal antiserum against chick CYP24 and CYP24-SV
A custom chick CYP24-SV peptide N'-(C)GKRFGLLQQDVEEES (CYP24-SV amino acid 55-69) sharing the same sequence with that of CYP24 and the custom rabbit polyclonal antiserum against this peptide were prepared and tested with HPLC and ELISA by SIGMA-GENOSYS Com. (Woodlands, TX). The antiserum titer determined by ELISA for the peptide-specific antibody was > 1: 500,000.
Western blot analysis HD-11 cells were pre-incubated with vehicle or 1,25-(OH) 2 D (200 nM) for 24 hr before extracting whole cell or mitochondrial protein. The mitochondrial extraction procedure was the same as previously described [28] .
The extracted mitochondrial pellets and the whole cultured cells were washed with PBS at room temperature and the protein extracts were then prepared by lysis of mitochondria and cells on ice with RIPA buffer (PBS, 0.5% sodium deosycholate, 0.2% triton x-100, 0.1%SDS, 1mM PMSF), passing through the 21 gauge needle to shear DNA and other cellular components, and centrifugation at 10,000xg for 10 minutes at 4°C. Micro BCA Protein Assay Reagent Kit (PIERCE, Rockford, IL) was used to determine protein concentration. 30 ug protein from each group was loaded for each lane on the 10% Tris-HCL Precast Gel and separated by the SDS-PAGE system following the protocol recommended by the supplier (Bio-Rad, Hercules, CA). Proteins were electrophoretically transferred onto a polyvinylidene difluoride (PVDF) membrane (Amersham Pharmacia Biotech Inc, Piscataway, NJ), probed with the rabbit polyclonal antiserum for the chick CYP24-SV (1: 500 diluted) and visualized by Western-Light detection system (Tropix, Bedord, MA) according to the manufacturer's instructions. For protein loading and mitochondrial expression positive control, the goat polyclonal IgG against GRP75 (Santa Cruz Biotechnology, Inc. Santa Cruz, CA 95060) (1:500 diluted) was also used to probe the western blot following the same procedure described above. The blots with the same protein loading but probed by the anti-cCYP24-SV and anti-GRP75 were compared.
Transfection of CYP24 and CYP24-SV expression constructs
Three cDNA expression constructs were prepared for transfection studies by RT-PCR using the primer pairs synthesized according to the sequences of chick CYP24 and its splice variant (CYP24-SV), each containing restriction enzyme excision sites. The sequences for these primer pairs were as The resulting PCR products were digested with XbaI and XhoI restriction enzyme sites, run on agarose gels, appropriate bands excised and the resulting cDNAs subcloned into a eukaryotic expression vector, pcDNA3.1 (Invitrogen, Carlsbad, CA).
After cloning and sequence analysis, expression constructs containing the sense and antisense cDNAs for CYP24 and CYP24-SV were transiently transfected into HD-11 cells by lipofection (LipoTAXI, Stratagene, La Jolla, CA) following the manufacturer's protocol. Briefly, HD-11 cells were seeded in wells on 12-well plates 24 hr prior to transfection and grown to 80 % confluence. 0.5 µg of plasmid DNA and 15 µl of LipoTAXI reagent were added in culture wells with DMEM alone. 5 hr later, an equal volume of DMEM containing 20% FBS was added to each well and another 16 hr later the media above was replaced by normal culture media. After 24 hr incubation in the normal culture media, the transfected cells were ready for vitamin D metabolism assessment (see below). For stable tranfection, 5 µg of plasmid DNA and 70 µl of LipoTAXI reagent were added to HD-11 cells in each 60-mm tissue culture dish following the same transfection procedure above.
After 24 hr incubation with normal culture medium, tranfected cells were cultured and maintained in DMEM containing 600 µg/ml G418 (Omega, Tarzana, CA). The media was changed every 3 days. Four weeks after, G418-resistant clones were picked and grown for further experiments.
Similar experiments were also carried out using sense and antisense expression constructs for hCYP24-SV. These constructs were produced using the following sets of primers However, for hCYP24-SV the transfection protocol for THP-1 cells was as follows: THP-1 cells in suspension were centrifuged and briefly washed with DMEM medium (GIBCO), seeded in wells on 12-well plates (5 x 10 6 cells per well) prior to transfection. Aliquots (2 µg) of plasmid DNA and 10 µl of LipoTAXI reagent were added in culture wells with DMEM alone.
6 hr later, an equal volume completed RPMI 1640 medium containing 20% FBS was added to each well and another 18 hr later, double volume of completed RPMI 1640 medium containing 10% FBS and 240 nM TPA was added, reaching the final concentration of 10% FBS and 160 nM TPA. After 24 hr exposure of TPA, the transiently transfected THP-1 cells were differentiated into macrophage-like dTHP-1 cells recognized by that 90% of the cells were found to be adhesive, and were ready for vitamin D metabolism assessment (see below). 
Measurement of 1,25-dihydroxyvitamin D (1,25-(OH) 2 D) production
RESULTS
Cloning and sequence analysis of a splice variant of the vitamin D-24-hydroxylase (CYP24-SV) in the chick macrophage cell-line HD-11
Using a series of primers based on the chicken 24-hydroxylase cDNA sequence, we cloned a novel 2.5 kb cDNA variant of CYP24 from chick macrophage HD-11 cells (GenBank TM /EBI accession number AF428109). The variant cDNA was 200 bp shorter than the published sequence for chick CYP24; the last 2324 bp showed almost 100% sequence identity to the chick CYP24 whereas the first 193 bp showed less than 40% identity (see appendix 1). Alignment with the genomic DNA sequence for chick CYP24 (GenBank TM /EBI accession number AY857864, see appendix 2) indicated that exons 1 and 2 were missing from the variant cDNA. Instead, the first 193 bp of the variant cDNA were derived from intron 2 of the CYP24 gene. This suggested that the 2.5 kb cDNA cloned from HD-11 cells was a splice variant of CYP24 and is subsequently referred to as CYP24-SV (Fig. 1) . Alternative splicing appears to occur at the intron 2/ exon 3 boundary, resulting in the 5' extension of exon 3 to include part of intron 2 from the stop codon at position 2306 of the genomic sequence (see appendix 2). Because of the stop codon located near the beginning of intron 2 (see appendix 2), the open reading frame (ORF) of the CYP24-SV was predicted to start at an ATG site at position 2547 of the CYP24 gene sequence which corresponded to position 243 of the CYP24-SV cDNA (Fig. 1) . The alternative splicing and translation start site did not result in a cDNA frame shift and it was therefore possible to predict a CYP24-SV protein which was 351 amino acids long (see appendix 3). This protein retained the same intact sterol-and heme-binding domains found in the holo-CYP24 protein (Fig. 1) . However, because the truncated CYP24-SV protein lacks the aminoterminal 156 amino acids of wild-type 24-OHase (508 amino acids), encoded by exon 1 and 2 of CYP24, it contained no mitochondrial targeting sequence.
Expression of CYP24-SV mRNA and protein in HD-11 cells
Expression of mRNA for CYP24-SV in HD-11 cells was initially examined by RT-PCR using primer combinations that were specific for splice variant and wild-type CYP24. In vehicle and 25-OHDtreated cells there was negligible expression of CYP24 (766 bp) and CYP24-SV (655 bp) but both transcripts were strongly upregulated following treatment with 1,25-(OH) 2 D (Fig. 2A) . Northern blot analysis (Fig. 2B ) was performed using a 715 bp probe (CYP24 cDNA 1104-1819) which was identical in CYP24-SV and CYP24. A single band of 2.7 kb was detected in cells cultured with 200 nM 1,25-(OH) 2 D for 24 hr. This suggested that the fulllength transcripts for CYP24 and CYP24-SV were approximately the same size, presumably reflecting further sequence variation in upstream parts of the 5' untranslated region of CYP24-SV yet to be sequenced. Western blot analysis using a rabbit polyclonal antiserum against CYP24 and CYP24-SV identified a 36 kDa band corresponding to the 351 amino acid fragment deduced from the ORF of CYP24-SV, as well as the 55 kDa CYP24 peptide (Fig. 2C) . However, unlike CYP24, this was only detectable in whole cell protein extracts, suggesting that the CYP24-SV protein resided outside the mitochondria. Expression of the 36 kDa CYP24-SV peptide was much stronger in 1,25-(OH) 2 D-treated cells, further emphasizing the positive control of the splice-variant by 1,25-(OH) 2 D.
Cloning of a human form of the CYP24-SV
Using primer combinations derived from the chick cDNA sequences outlined above, a human equivalent of CYP24-SV was cloned and sequenced (GenBank TM /EBI accession number AY858838, see appendix 4). The cDNA, referred to as hCYP24-SV, showed exactly the sequence organization as the chick CYP24-SV in that exons 1 and 2 were spliced out and replaced by an alternative sequence derived from intron 2 (Fig. 3A) . The resulting protein sequence for hCYP24-SV was 372 amino acids long compared to 513 amino acids for holo human CYP24 (Fig. 3b) . As with the chick splice variant, hCYP24-SV protein included no mitochondrial target sequence but retained steroland heme-binding domains (see appendix 5).
Tissue distribution of hCYP24-SV
RT-PCR analyses of various human tissues indicated that hCYP24-SV was present in kidney, placenta, skin and primary cultures of macrophages. In each case expression of the 396 bp species corresponding to hCYP24-SV was more abundant than the corresponding 484 bp wild type CYP24 mRNA. By contrast the splice variant was only weakly expressed in brain and was undetectable in heart (Fig. 4) . In the human monocyte/macrophage cell line THP-1, expression of both hCYP24-SV and hCYP24 was potently upregulated after treatment with 1,25-(OH) 2 D (100 nM for 24 hrs). This effect was observed in conventional THP-1 cultures and also in THP-1 cells differentiated toward a more mature macrophage phenotype by treatment with phorbol ester (dTHP-1 cells).
CYP24-SV and hCYP24-SV regulate 1,25-(OH) 2 D production by macrophages
Compared to the holo-enzyme, the CYP24-SV and hCYP24-SV showed identical sequence in the sterol binding domains. However, by contrast, both of the splice variant cDNAs had deduced amino acid sequences which did not include mitochondrialtargeting domains. therefore, it was postulated that, when expressed, CYP24-SV and hCYP24-SV might function in an entirely different fashion to 24-OHase with respect to the attenuation of 1,25-(OH) 2 D production. To test this hypothesis expression constructs containing sense and antisense sequences for CYP24-SV and hCYP24-SV were transfected into 1α-OHase-positive HD-11 cells and differentiated THP-1 cells respectively ( Fig. 5A and 5B). Transient transfection with antisense cDNA increased 1,25-(OH) 2 D production in HD-11 cells by 7-fold (p<0.001), whereas sense cDNA for CYP24-SV suppressed production of 1,25-(OH) 2 D by 50% (p<0.01). These data were generated using a substrate (25-OHD) concentration (200 nM) that approximated to the reported Km values for 1α-hydroxylase and 24-hydroxylase. However, similar levels of CYP24-SV-induced suppression of 1,25-(OH) 2 D production were also observed using 20 or 2000 nM 25-OHD (68% of control, P<0.01 and 55% of control, p<0.01 respectively) (Fig. 5C) . Modulation of 1α-hydroxylase activity by CYP24-SV was also observed in TPA-differentiated THP-1 cells where antisense cDNA for hCYP24-SV increased 1,25-(OH) 2 D production 2-fold (p<0.001) and sense cDNA suppressed production by 40% (p<0.01). Transfection of CYP24 cDNA had little effect on the synthesis of 1,25-(OH) 2 D by HD-11 cells, and transfection of the splice variant cDNAs had no effect on 24-hydroxylase activity which remained undetectable in both HD-11 and THP-1 cells (data not shown). (30, 31) or by CYP24 gene ablation (32, 33) . In each case the overriding consequence of 24-OHase knockout was to sensitize tissues to the effects of 1,25-(OH) 2 D. As CYP24 is perhaps the most sensitively regulated of all the many target genes for 1,25-(OH) 2 D, it seems likely that this feedback control mechanism will operate at most sites of 1,25-(OH) 2 D synthesis and action. However, one abundant source of extrarenal 1α-OHase activity that does not appear to be subject to 24-OHase-mediated control is the macrophage (22) (23) (24) . Indeed autocrine synthesis of 1,25-(OH) 2 D associated with inflammatory diseases such as sarcoidosis (34) and Crohn's disease (35) is commonly dysregulated, and may lead to increased circulating levels of 1,25-(OH) 2 D and concomitant hypercalcemia or hypercalciuria (36). We therefore postulated that the elevated synthesis of 1,25-(OH) 2 D observed in macrophages may involve a regulatory system that is distinct from the 24-OHase-mediated mechanism found in most other cell types.
Using chick and human macrophage models, we cloned and characterized a CYP24 splice variant which is also detectable in the kidney and other extra-renal tissues. The human form, hCYP24-SV, retains the upstream VDREs that are present in CYP24 and consequently demonstrates the same sensitive induction by 1,25-(OH) 2 D characteristic of the wild-type species (6, 7). hCYP24-SV also retains the intact sterol bind domain common to other vitamin D metabolic P450 enzymes (see Fig.  4) , and is therefore able to bind substrates such as 25-OHD or 1,25-(OH) 2 D. However, unlike holo CYP24, the splice variant lacks a 150 amino acid amino-terminal sequence containing the mitochondrial targeting domain (37-39). The loss of such a moiety presumably leaves the CYP24-SV protein with no conventional means of translocation through the mitochondria membranes (40). Thus, the variant protein will not be processed into a functionally mature enzyme: when a protein moves into the mitochondrion its presequence (with a range of approximately 10-80 amino-acid residues) is cleaved by a mitochondrial processing peptidase and the resulting mature protein folds into its functional confirmation (41, 42). This was further supported by Western blot analyses which provided direct evidence for the exo-mitochondrial localization of CYP24-SV protein (Fig. 4) .
Mitochondrial P450 activity is dependent on the NADPH-adrenodoxin-reductase-electron-transport system located within the mitochondrion, suggesting that the CYP24-SV and hCYP24-SV proteins will be functionally inactive. This was confirmed by stable and transient transfection studies in which over-expression of the human or chick CYP24-SV failed to produce any 24-hydroxylase activity. Despite this, modulation of CYP24-SV expression had significant effects on 1,25-(OH) 2 D production, with 1α-OHase activity being increased by antisense CYP24-SV and decreased by sense CYP24-SV expression (Fig. 5) . The ability of CYP24-SV to suppress synthesis of 1,25-(OH) 2 D was still evident at saturating doses of substrate. A possible explanation for this is that the splice variant functions in a non-catabolic fashion by competing with 1α-OHase for substrate, although alternative splicing in cytochrome P450 genes has previously been shown to cause changes in function, activity, substrate preference and tissue-specificity (43-46). Our current study is the first example of alternative splicing in CYP24 gene, although Neve and colleagues have previously reported that deletion of 95 amino acids at the N-terminus of the CYP2E1 protein abolished its mitochondrial targeting (40). CYP27B1 splice variants have also been reported in malignant glioma cells, although the functional significance of the resulting cDNAs is unclear (47).
Expression studies presented here suggest that hCYP24-SV acts by sequestering vitamin D metabolites but several important questions concerning the function of this peptide remain to be answered.
In common with the holoenzyme transcription of hCYP24-SV was potently upregulated following treatment with 1,25-(OH) 2 The underlying basis for the regulation of alternative splicing in the CYP24 gene is still unclear and may involve changes in the levels of ubiquitous splicing factors such as heterogeneous nuclear ribonuclear protein A1 (hnRNP A1) or induction of tissue or signal specific splicing factors (48). As both CYP24 and CYP24-SV contain upstream VDRE sequences and show similar levels of induction with 1,25-(OH) 2 D it seems likely that other factors will be involved in mediating the differential splicing of this gene. A possible candidate for this is PTH which has been shown to potentiate 1,25-(OH) 2 D-mediated transcription of CYP24 with a concomitant increase in 24-OHase protein (49).
RNA splicing is a common feature of more advanced organisms with up to 60% of human genes being alternatively spliced (48). Although this confers an expression advantage by expanding the capacity for regulation of RNA and the diversity of proteins, the specific biological benefit of a 24-hydroxylase variant remains unclear. CYP24-SV may reflect the dichotomy between classical calciotropic and non-classical antiproliferative/immunomodulatory functions of 1,25-(OH) 2 D. Alternatively, the presence of CYP24 and CYP24-SV proteins may simply underline the need for sensitive control of vitamin D responses. In either case the expression of CYP24-SV may have important pathological implications.
In particular, the presence of this peptide in activated macrophages suggests that it may be a contributing factor to the elevated serum 1,25-(OH) 2 D frequently seen with inflammatory diseases (34) (35) (36) (37) ). The precise mechanism by which this occurs is still to be elucidated but may involve an additional facet of CYP24-SV function. Specifically, studies presented here have focused on the ability of the splice-variant protein to suppress 1α-OHase activity presumably by sequestering the substrate for this enzyme 25 cDNA with an incomplete 5' sequence and a 3' poly A tail. The first 193 bp of the cloned cDNA had less than 40% identity with CYP24 cDNA, whereas the remaining sequence shared more than 99% homology with CYP24 (see appendix 1). Sequence analysis of chick genomic DNA (see appendix 2) indicated that, unlike CYP24, the novel cDNA did not include exons 1 and 2 of the CYP24 gene and it was therefore referred to as a splice variant of CYP24 (CYP24-SV). The first 193 bp of CYP24-SV were derived from intron 2 of CYP24 to form an extended exon 3. A stop codon (TAA) was identified at the beginning of CYP24-SV, although this was upstream of a translation initiator codon (ATG) located at nucleotide 243 of CYP24-SV (position 481 CYP24) which encoded an open reading frame for CYP24-SV. By contrast the translation initiator codon (atg) for CYP24 was located in exon 1 of CYP24. Analysis of the deduced amino acid sequence (see appendix 3), showed that the 156 N-terminal amino acids encoded by exon 1-2 of CYP24 were truncated in CYP24-SV, leading to the absence of the CYP24 mitochondrial membrane targeting sequence (shown in italics). The remaining 351 amino acids of CYP24-SV were >99% homologous with 24-OHase, including the sterol-and heme-binding domains (both underlined). Sequence data are shown for exons 1, 2 and 3 of chick CYP24 only with the remaining CYP24 and CYP24-SV cDNAs showing >99% identity. D (100 nM, 24 hrs) . A 55 kDa band corresponding to wild type CYP24 was also detected using this antiserum. Protein loading for Western blots was assessed by expression of the mitochondrial resident housekeeping gene grp75. peripheral blood-derived macrophages (macrophage); keratinocytes (skin); heart; and brain. RNA was also isolated from THP-1 cells treated with or without 100 nM 1,25-(OH) 2 D (1,25D) for 24 hrs in the presence or absence of 160 nM TPA as an alternative differentiating agent (dTHP-1/dTHP-1 + 1,25D). RT-PCR assays were carried out as multiplex assays using primers for hCYP24 and hCYP24-SV together with primers for the housekeeping gene β-actin. 
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used to clone a novel 2.5 kb CYP24 cDNA with an incomplete 5' sequence and a 3' poly A tail. The first 193 bp of the cloned cDNA had less than 40% identity with CYP24 cDNA, but the remaining 2.3 kb shared more than 99% homology with CYP24. The cloned 2.5 kb cDNA from HD-11 cells was referred to as a splice variant of CYP24 (CYP24-SV). A stop codon (TAA) located at the beginning of the 193 bp fragment was identified, although this was upstream of the first translation initiator codon (ATG) located at nucleotide 243 of CYP24-SV. The cDNA sequences were aligned using the GAP program in GCG. 5' G GGTGAACGGG GGCA 3' 1551 CCTGTGCCCT CCTGCCTCGC CTGAACCCTT TGTGAACCGC TTGCCCCGCA 3' ACG GGGGCAAGTG GG 5' 1601 AACTCCCCGG GCCGGGCCAC GCCAGCCTGC CCCACCTCAC CCCACCCAGG 
